writer, health care advocate, physician
One problem is that prospective, randomized clinical trials comparing treatments for conditions like “Stage 3 ovarian cancer” fall behind the pace of advances in science and drug development.
Chemotherapy treatments for early-stage breast cancer vary widely in their possible side effects. But few newly-diagnosed patients press their oncologists about those differences.
Few cancer patients take notes on chemo dose options and potential long-term side effects.
New research helps clarify what chemobrain is and why it happens.
Understanding breast cancer biology provides some new targets.
